Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its blockbuster Wegovy obesity drug in the key U.S. market. The company also named Maziar Mike …
Read More »Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance
